Mark D. McDade Reappointed As Independent Director Of Lupin

Lupin Limited today announced the reappointment of Mark D. McDade as an Independent Director, effective January 28, 2026, subject to approval by the company’s members.

McDade brings more than four decades of experience in the global biopharmaceutical industry, with expertise spanning Corporate Governance, leadership, and general management. His professional background covers a wide spectrum, including healthcare, pharma, science and technology, manufacturing, quality and supply chain, risk management, ESG, information technology (IT), and mergers and acquisitions (M&A). McDade’s extensive boardroom and executive experience equip him with a strong understanding of industry dynamics and stakeholder expectations. He holds a Bachelor of Arts degree from Dartmouth College, Hanover, and an MBA from Harvard Business School, Boston.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: